T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies

Conditions:   Bladder Carcinoma;   Breast Cancer;   Esophagus Carcinoma;   Lung Cancer;   Melanoma;   Multiple Myeloma;   Neuroblastoma;   Ovarian Cancer;   Synovial Sarcoma;   Other Metastatic Solid Cancers
Interventions:   Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Anti-NY ESO-1 TCR-transduced T cells
Sponsors:   Shenzhen Second People's Hospital;   Shenzhen institute for innovation and translational medicine
Recruiting - verified August 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/2aT2axg
via IFTTT